PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis. - Test2 - elhamkhani - TriplyDB

PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.

PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.

http://www.wikidata.org/entity/Q41879222

about

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.Dynamic changes of early-stage aortic lipid deposition in chronic renal failure rats and effects of decorin gene therapy.Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice PAI-1 in tissue fibrosis.MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells.Up-regulation of peroxisome proliferator-activated receptor gamma in radiation-induced heart injury in rats.Development and validation of a high throughput LC-MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study.Activation of PPAR-γ inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor.

P2860

Q27336127-8AACB009-405D-4AF9-A1B9-C8ED04760967 Q28489058-99A454A6-15D6-4904-A9C1-BD7D417A87A8 Q34355908-A6EE3D97-3ADC-476D-A898-FE576217DB06 Q34795819-10A19B9D-4A35-44A2-9781-7857D01043BA Q35115765-B77BF992-73DE-4586-843A-48E20512011F Q37565264-19AF4D40-E27D-423E-94B7-0958030ECD6A Q37723232-CFF6BA5D-3CE0-4135-9E7B-048319F6DD7A Q37861626-947628DB-F348-4079-A3D9-57AEF8D75B91 Q39194879-295DFD53-B45C-4D82-ADD3-9E407B0ABC86 Q44793448-303BF9AA-923D-4BCB-8BD3-04F2DBA122C0 Q49202339-DE6E68B3-72FE-430B-861E-0921FFFFB62F Q54188393-F849109F-3070-4DA2-BDE7-10FA459A6000

P2860

PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.

http://www.wikidata.org/entity/Q41879222

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

PPARgamma agonist and angioten ...... l tubulointerstitial fibrosis.

@en

type

label

PPARgamma agonist and angioten ...... l tubulointerstitial fibrosis.

@en

prefLabel

PPARgamma agonist and angioten ...... l tubulointerstitial fibrosis.

@en

P1433

Q41879222-4A5CD2F3-9D17-45C8-AC6C-0F9F6C61F515

P1476

Q41879222-C2198D50-B1D7-4139-B620-50BA4A98C433

P2093

Q41879222-00F3E8F6-C2B9-468F-BD9E-2FDBB72A8A6C

Q41879222-0AA2B8A8-3A47-423C-9220-19DE838C5883

Q41879222-4F1324CA-9FDB-44EE-BF38-E20E8C0D92A6

Q41879222-753D775C-C6EE-4E45-91D6-FD928B6B3FF1

Q41879222-8AC110FA-22C9-43F8-AB2B-ED3BDDD41261

Q41879222-A5FCF9FF-E648-4625-A398-509E75EEF0AB

Q41879222-C2C67FF7-4109-4FFA-B0F0-6EA55BBD405E

Q41879222-ECADC723-D119-4A57-AD09-27EC3A4974F2

P2860

Q41879222-227BA2BA-B020-4052-90FC-01914D5A318C

Q41879222-35A5145A-946A-496D-9336-CBBDF586CA05

Q41879222-3657AE26-BE4B-48B5-82CD-CCBCA8F0D52F

Q41879222-36FCD7DE-A64A-4917-91F7-D9C9DDF9619D

Q41879222-392EFC81-8656-49A0-A0B1-0BBB871D101F

Q41879222-3D71E9BA-2820-4795-8AA6-1B23B2543ACC

Q41879222-58EE5290-AD12-4F28-9AEF-81F41DF84A7B

Q41879222-6A9B0C10-E0B6-466A-9881-13F5266B57F1

Q41879222-6BFDE236-2057-49BA-92F4-9C98305115FE

Q41879222-71385C9D-A18A-4DD3-8762-78FEE41F2F4D

P304

Q41879222-1EF5A6D0-D142-4977-9394-DE985BB3205F

P31

Q41879222-2363CCCD-3849-4D03-B7A2-C013E61A644F

P356

Q41879222-6C5936DA-5EEA-45C1-9240-E5853DBAA040

P433

Q41879222-7EE6D5F3-09AE-4FF4-B422-6DAA495E912E

P478

Q41879222-8826DFCE-7DB1-4475-86F8-8074458DB501

P577

Q41879222-8FABD4B8-9D69-43B9-8006-F0AC75A8E648

P5875

Q41879222-5479E147-799B-41FF-83E3-EC86C51C2384

P698

Q41879222-03A7BA20-FD70-47AD-B7C3-2F2C08DF5A37

P932

Q41879222-B3BAE5EC-583A-4E39-901A-C8183E3D7BD2

P356

JKMS.2010.25.1.35

P1433

Journal of Korean Medical Science

P1476

PPARgamma agonist and angioten ...... l tubulointerstitial fibrosis.

@en

P2093

Dae-Ryong Cha

http://www.w3.org/2001/XMLSchema#string

In-Suh Park

http://www.w3.org/2001/XMLSchema#string

Jee-Young Han

http://www.w3.org/2001/XMLSchema#string

Joon-Mee Kim

http://www.w3.org/2001/XMLSchema#string

Lucia Kim

http://www.w3.org/2001/XMLSchema#string

Suk-Jin Choi

http://www.w3.org/2001/XMLSchema#string

Ye-Ji Kim

http://www.w3.org/2001/XMLSchema#string

Young Chae Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Controlling TGF-beta signaling

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis.

Plasminogen activator inhibitor-1 and the kidney.

Molecular basis of renal fibrosis.

Aldosterone and PAI-1: implications for renal injury.

hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.

Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion.

Macrophages and progressive renal disease in experimental hydronephrosis.

P304

35-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3346/JKMS.2010.25.1.35

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40851161

http://www.w3.org/2001/XMLSchema#string

P698

20052345

http://www.w3.org/2001/XMLSchema#string

P932

2799997

http://www.w3.org/2001/XMLSchema#string